According to Abiomed's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 15.9955. At the end of 2022 the company had a P/S ratio of 10.4.
Year | P/S ratio | Change |
---|---|---|
2022 | 10.4 | -36.17% |
2021 | 16.3 | -9.61% |
2020 | 18.0 | 97.01% |
2019 | 9.15 | -53.98% |
2018 | 19.9 | 30.49% |
2017 | 15.2 | 29.19% |
2016 | 11.8 | -6.71% |
2015 | 12.6 | 72.33% |
2014 | 7.33 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Boston Scientific BSX | 7.56 | -52.77% | ๐บ๐ธ USA |
Teleflex TFX | 3.28 | -79.52% | ๐บ๐ธ USA |
AtriCure ATRC | 2.81 | -82.43% | ๐บ๐ธ USA |